These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 3096127

  • 21. Current state of thrombolytic therapy.
    Vorchheimer DA.
    Curr Cardiol Rep; 1999 Sep; 1(3):212-20. PubMed ID: 10980844
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial.
    Ross AM, Gao R, Coyne KS, Chen J, Yao K, Yang Y, Qin X, Qiao S, Yao M, TUCC Investigators.
    Am Heart J; 2001 Aug; 142(2):244-7. PubMed ID: 11479462
    [Abstract] [Full Text] [Related]

  • 24. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM.
    JAMA; 1996 Mar 13; 275(10):777-82. PubMed ID: 8598594
    [Abstract] [Full Text] [Related]

  • 25. Is the streptokinase responsible for the endothelial injury and the platelet activation during fibrinolytic therapy?
    Kolev K, Skopál J, Nagy Z, Machovich R.
    J Intern Med; 2001 May 13; 249(5):475-6. PubMed ID: 11350572
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fibrin-specific thrombolytic agents.
    Collen D.
    Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1791-8. PubMed ID: 3122317
    [Abstract] [Full Text] [Related]

  • 30. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D.
    Prog Hemost Thromb; 1986 Nov 14; 8():1-18. PubMed ID: 3104986
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Thrombolytic therapy].
    Matsuda T.
    Nihon Rinsho; 1998 Oct 14; 56(10):2577-81. PubMed ID: 9796322
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Thrombolytic therapy for pulmonary thromboembolism].
    Pankov KS.
    Klin Med (Mosk); 2004 Oct 14; 82(10):4-8. PubMed ID: 15584590
    [No Abstract] [Full Text] [Related]

  • 35. [The choice of appropriate thrombolytic agents as therapy in acute heart infarct].
    Görge G, Meyer J.
    Med Klin (Munich); 1992 Feb 15; 87(2):70-80, 108. PubMed ID: 1542286
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Streptokinase versus alteplase in acute myocardial infarction.
    Friedman HS.
    J R Soc Med; 1996 Aug 15; 89(8):427-30. PubMed ID: 8795494
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction.
    von Hodenberg E, Kreuzer J, Hautmann M, Nordt T, Kübler W, Bode C.
    Am J Cardiol; 1991 Jun 15; 67(16):1349-53. PubMed ID: 1828324
    [Abstract] [Full Text] [Related]

  • 40. [Thrombolytic therapy of acute myocardial infarction].
    Chen JL.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 05; 85(1):69-70. PubMed ID: 15808085
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.